SI5 Global
✓ Produto localizado
Produtos Farmacêuticos

EBASTEL XPE

EUROFARMA
GTIN / EAN
7891317000547
Conteúdo
Não informado

Dados de produto preservados no idioma original.

EBASTEL XPE é fabricado pela EUROFARMA, na categoria Produtos Farmacêuticos, com código de barras 7891317000547. Classificado no NCM 30049069 (Outros), CEST 1300101.

Fonte: SI5 Global · código registrado em Brasil · atualizado em 03/10/2026

WhatsApp

Preço base (referência): R$ 61,99 — coletado em paguemenos.com.br em 03/10/2026, pode não estar atualizado

Preço nos últimos 30 dias: R$ 61,99 em 1 loja

Código de barras

7891317000547

Código de barras 7891317000547

Código registrado em Brasil · prefixo 789

Classificação fiscal

NCM
30049069Outros
CEST
130010113. Medicamentos de uso humano e outros produtos farmacêuticos para uso humano ou veterinário

Descrição do produto

O que é Ebastel 1mg/ml Xarope 60ml?

O Ebastel 1mg/ml Xarope 60ml é um medicamento anti-histamínico, também conhecido como antialérgico, que atua na prevenção dos efeitos da histamina, uma substância liberada pelo corpo durante reações alérgicas. Sua principal função é aliviar os sintomas associados à rinite alérgica, como coriza, espirros, coceira e congestão nasal, além de tratar a urticária, diminuindo a coceira e o ardor característicos das lesões na pele. O tempo para o início de sua ação varia de 1 a 3 horas após a administração, proporcionando alívio eficaz e duradouro dos desconfortos alérgicos para adultos e crianças.

Conteúdo da embalagem: 1 frasco de 60ml de xarope, 1 seringa dosadora e 1 adaptador.

Fabricado por: Eurofarma

Indicação etária: Uso adulto e pediátrico acima de 2 anos.

Composição Ebastel 1mg/ml Xarope 60ml:

Princípio ativo: ebastina 1mg/ml

Excipientes: ácido lático, óleo de rícino hidrogenado, neohesperidina, anetol, metilparabeno, propilparabeno, glicerol, sorbitol, simeticona, hidróxido de sódio, água.

Para que serve Ebastel?

Ebastel é indicado para o tratamento e alívio de sintomas de condições alérgicas. Sua ação anti-histamínica é eficaz para:

  • Tratamento da rinite alérgica: Alivia sintomas como secreção nasal (coriza), espirros, coceira e entupimento nasal, que podem estar associados ou não à conjuntivite alérgica (olhos vermelhos, lacrimejando e com coceira).
  • Tratamento da urticária: Reduz os sintomas de coceira e ardor na pele causados por lesões avermelhadas e elevadas.

Como devo tomar Ebastel 1mg/ml Xarope 60ml?

A administração de Ebastel xarope deve ser feita por via oral, utilizando a seringa dosadora que acompanha o produto para garantir a dose correta. A posologia recomendada varia conforme a idade:

  • Crianças com idade entre 2 e 5 anos: A dose recomendada é de 2,5ml de solução oral (correspondente a 2,5mg de ebastina) uma vez ao dia.
  • Crianças com idade entre 6 a 11 anos: A dose recomendada é de 5ml de solução oral (correspondente a 5mg de ebastina) uma vez ao dia.
  • Adultos e crianças acima de 12 anos: A dose recomendada é de 10ml de solução oral (correspondente a 10mg de ebastina) uma vez ao dia.

Siga sempre a orientação do seu médico ou farmacêutico.

Quando não devo tomar Ebastel?

O uso de Ebastel é contraindicado e não deve ser utilizado nos seguintes casos:

  • Pacientes com hipersensibilidade (alergia) à ebastina ou a qualquer outro componente da fórmula.
  • Crianças menores de 2 anos de idade.
  • Pacientes com insuficiência hepática grave.
  • Mulheres grávidas sem orientação médica ou do cirurgião-dentista.

Ficha técnica

Medicamento
True
MarcaPropria
Não
NumeroRegistroMS
1.0043.0760.003-1
NomeSubstanciaPrincipioAtivo
Ebastina
DescricaoBula
%0A%09%09%09%09%09%09%3Ch2%3ELaborat%26%23xF3%3Brio%3C%2Fh2%3E%0A%3Cp%3EEurofarma%3C%2Fp%3E%0A%3Ch2%3E%20Apresenta%26%23xE7%3B%26%23xE3%3Bo%20EBASTEL%20%3C%2Fh2%3E%0A%3Cp%3EComprimidos%20revestidos%3Cbr%3E%20Embalagens%20com%2010%20comprimidos%20revestidos%20contendo%2010%20mg%20de%20ebastina.%3Cbr%3E%20%3Cbr%3E%20Solu%26%23xE7%3B%26%23xE3%3Bo%20Oral%3Cbr%3E%20Embalagem%20com%20frasco%20de%20vidro%20de%2060%20mL%20contendo%201%20mg%2FmL%20de%20ebastina.%3Cbr%3E%20%3Cbr%3E%20USO%20ORAL%3Cbr%3E%20%3Cbr%3E%20Comprimido%3Cbr%3E%20USO%20ADULTO%20E%20USO%20PEDI%26%23xC1%3BTRICO%20ACIMA%20DE%2012%20ANOS%3Cbr%3E%20%3Cbr%3E%20Solu%26%23xE7%3B%26%23xE3%3Bo%20Oral%3Cbr%3E%20USO%20ADULTO%20E%20PEDI%26%23xC1%3BTRICO%20ACIMA%20DE%202%20ANOS%3Cbr%3E%20%3Cbr%3E%20Composi%26%23xE7%3B%26%23xE3%3Bo%3A%3Cbr%3E%20Ebastel%26%23xAE%3B%20comprimidos%3Cbr%3E%20Cada%20comprimido%20revestido%20cont%26%23xE9%3Bm%3A%3Cbr%3E%20ebastina%20%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x2026%3B.%26%23x85%3B%26%23x85%3B.10%20mg%20%3Cbr%3E%20Excipientes%20q.s.p%20%26%23x85%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B.%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x85%3B%26%23x2026%3B%26%23x2026%3B..1%20comprimido%3Cbr%3E%20Excipientes%3A%20celulose%20microcristalina%2C%20amido%2C%20lactose%20monoidratada%2C%20croscarmelose%20s%26%23xF3%3Bdica%2C%20estearato%20de%20magn%26%23xE9%3Bsio%2C%20hipromelose%2C%20macrogol%20e%20di%26%23xF3%3Bxido%20de%20tit%26%23xE2%3Bnio.%3Cbr%3E%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%3Cbr%3E%20Cada%20mL%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oralcont%26%23xE9%3Bm%3A%3Cbr%3E%20ebastina%20%26%23x85%3B%26%23x85%3B%26%23x85%3B.%26%23x85%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x2026%3B%26%23x85%3B1%2C0%20mg%20%3Cbr%3E%20Excipientes%20q.s.p%20%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x85%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B%26%23x2026%3B..%26%23x85%3B1%2C0%20mL%3Cbr%3E%20Excipientes%3A%20%26%23xE1%3Bcido%20l%26%23xE1%3Btico%2C%20glicerina%20polietilenoglicol%20oxiestearato%2C%20neohesperidina%2C%20anetol%2C%20metilparabeno%2C%20proprilparabeno%2C%20glicerol%2C%20sorbitol%20dimetilpolixiloxana%2C%20hidr%26%23xF3%3Bxido%20de%20s%26%23xF3%3Bdio%2C%20%26%23xE1%3Bgua.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3E%20EBASTEL%20%26%23x2013%3B%20Indica%26%23xE7%3B%26%23xF5%3Bes%20%3C%2Fh2%3E%0A%3Cp%3EEbastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20indicado%20para%20o%20tratamento%20sintom%26%23xE1%3Btico%20da%20rinite%20al%26%23xE9%3Brgica%20intermitente%20e%20da%20rinite%20al%26%23xE9%3Brgica%20persistente%2C%20associadas%2C%20ou%20n%26%23xE3%3Bo%20%26%23xE0%3B%20conjuntivite%20al%26%23xE9%3Brgica.%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20tamb%26%23xE9%3Bm%20est%26%23xE1%3B%20indicado%20no%20tratamento%20da%20urtic%26%23xE1%3Bria%20idiop%26%23xE1%3Btica.%3C%2Fp%3E%0A%3Ch2%3E%20Contra%20indica%26%23xE7%3B%26%23xF5%3Bes%20de%20EBASTEL%20%3C%2Fh2%3E%0A%3Cp%3EEbastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20contraindicado%20para%20pacientes%20com%20hipersensibilidade%20conhecida%20%26%23xE0%3B%20ebastina%2C%20ou%20aos%20demais%20componentes%20da%20formula%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave.%20Este%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20menores%20de%202%20anos.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20gr%26%23xE1%3Bvidas%20sem%20orienta%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20ou%20do%20cirurgi%26%23xE3%3Bo-dentista.%3Cbr%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3EAdvert%26%23xEA%3Bncias%3C%2Fh2%3E%0A%3Cp%3EEbastel%26%23xAE%3B%20(ebastina)%20n%26%23xE3%3Bo%20deve%20ser%20administrado%20em%20caso%20de%20rea%26%23xE7%3B%26%23xE3%3Bo%20anafil%26%23xE1%3Btica%20que%20necessite%20de%20aten%26%23xE7%3B%26%23xE3%3Bo%20urgente%2C%20j%26%23xE1%3B%20que%20o%20efeito%20terap%26%23xEA%3Butico%20aparece%201a%203%20horas%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20n%26%23xE3%3Bo%20deve%20ser%20administrado%20em%20crian%26%23xE7%3Bas%20menores%20de%202%20anos%20de%20idade%2C%20pois%20a%20seguran%26%23xE7%3Ba%20n%26%23xE3%3Bo%20foi%20estabelecida%20nesta%20faixa%20et%26%23xE1%3Bria.%3Cbr%3E%20Como%20acontece%20com%20outros%20anti-histam%26%23xED%3Bnicos%2C%20deve-se%20ter%20cautela%20quando%20do%20uso%20de%20Ebastel%26%23xAE%3B%20(ebastina)%20em%20pacientes%20com%20s%26%23xED%3Bndrome%20do%20intervalo%20QT%20longo%20(resultados%20anormais%20de%20estudos%20da%20fun%26%23xE7%3B%26%23xE3%3Bo%20cardiovascular%2C%20eletrocardiograma%20anormal)%2C%20hipopotassemia%2C%20tratamento%20com%20qualquer%20medicamento%20que%20provoque%20aumento%20do%20intervalo%20QT%2C%20ou%20inibi%26%23xE7%3B%26%23xE3%3Bo%20dos%20sistemas%20enzim%26%23xE1%3Bticos%20CYP3A4%2C%20tais%20como%20antif%26%23xFA%3Bngicos%20azois%20e%20antibi%26%23xF3%3Bticos%20macrol%26%23xED%3Bdeos%20(vide%20%26%23x93%3Bintera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%26%23x94%3B).%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20deve%20ser%20utilizado%20com%20cautela%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20ou%20hep%26%23xE1%3Btica%20de%20intensidade%20leve%20a%20moderada%20(vide%20%26%23x93%3Bposologia%26%23x94%3B%20e%20%26%23x93%3Bpropriedades%20farmacocin%26%23xE9%3Bticas%26%23x94%3B).%3Cbr%3E%20%3Cbr%3E%20Efeitos%20sobre%20a%20habilidade%20para%20dirigir%20e%20operar%20m%26%23xE1%3Bquinas%3Cbr%3E%20A%20fun%26%23xE7%3B%26%23xE3%3Bo%20psicomotora%20foi%20extensivamente%20estudada%20em%20humanos%2C%20sendo%20que%20n%26%23xE3%3Bo%20foram%20encontrados%20efeitos%20nas%20doses%20terap%26%23xEA%3Buticas%20recomendadas.%20Um%20estudo%20realizado%20para%20avaliar%20a%20habilidade%20para%20dirigir%20indicou%20que%20a%20ebastina%20n%26%23xE3%3Bo%20provoca%20preju%26%23xED%3Bzo%20da%20capacidade%20para%20dirigir%2C%20mesmo%20na%20dose%20de%2030%20mg.%20Com%20base%20nestes%20resultados%2C%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20ebastina%20nas%20doses%20terap%26%23xEA%3Buticas%20recomendadas%20n%26%23xE3%3Bo%20afeta%20a%20habilidade%20para%20dirigir%2C%20ou%20operar%20m%26%23xE1%3Bquinas.%3Cbr%3E%20%3Cbr%3E%20Categoria%20de%20risco%20na%20gravidez%3A%20C%3Cbr%3E%20A%20seguran%26%23xE7%3Ba%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20ebastina%20durante%20a%20gravidez%20humana%20ainda%20n%26%23xE3%3Bo%20foi%20estabelecida.%20Estudos%20em%20ratos%20e%20camundongos%20n%26%23xE3%3Bo%20indicaram%20qualquer%20efeito%20nocivo%20direto%2C%20ou%20indireto%20sobre%20o%20desenvolvimento%20embrion%26%23xE1%3Brio%2C%20ou%20fetal%2C%20durante%20a%20gesta%26%23xE7%3B%26%23xE3%3Bo%2C%20ou%20desenvolvimento%20peri%20e%20p%26%23xF3%3Bs-natal.%20N%26%23xE3%3Bo%20foram%20identificados%20efeitos%20teratog%26%23xEA%3Bnicos%20em%20animais%3B%20por%26%23xE9%3Bm%2C%20n%26%23xE3%3Bo%20existem%20estudos%20bem-controlados%20em%20mulheres%20gr%26%23xE1%3Bvidas%20e%20estudos%20reprodutivos%20nem%20sempre%20s%26%23xE3%3Bo%20demonstrativos%20da%20resposta%20humana.%20Portanto%2C%20a%20ebastina%20s%26%23xF3%3B%20deve%20ser%20utilizada%20durante%20a%20gravidez%2C%20em%20caso%20de%20necessidade%20evidente.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20gr%26%23xE1%3Bvidas%20sem%20orienta%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20ou%20do%20cirurgi%26%23xE3%3Bo-%20dentista.%3Cbr%3E%20%3Cbr%3E%20Lacta%26%23xE7%3B%26%23xE3%3Bo%3Cbr%3E%20N%26%23xE3%3Bo%20se%20conhece%20a%20respeito%20da%20excre%26%23xE7%3B%26%23xE3%3Bo%20da%20ebastina%20no%20leite%20materno%3B%20portanto%2C%20Ebastel%26%23xAE%3B%20(ebastina)%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20que%20estejam%20amamentando.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EIntera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%20de%20EBASTEL%3C%2Fh2%3E%0A%3Cp%3EA%20ebastina%20pode%20potencializar%20o%20efeito%20de%20outros%20anti-histam%26%23xED%3Bnicos.%3Cbr%3E%20Foram%20observadas%20intera%26%23xE7%3B%26%23xF5%3Bes%20farmacocin%26%23xE9%3Bticas%20e%20farmacodin%26%23xE2%3Bmicas%20com%20as%20associa%26%23xE7%3B%26%23xF5%3Bes%20ebastina%20e%20cetoconazol%2C%20ou%20eritromicina%20(ambos%20conhecidos%20por%20prolongar%20o%20intervalo%20QT)%2C%20relatando-se%20um%20aumento%20de%2018-19%20mseg%20(4%2C7%20%26%23x2013%3B%205%25)%20no%20intervalo%20QT.%20O%20itraconazol%20pode%20aumentar%20os%20n%26%23xED%3Bveis%20s%26%23xE9%3Bricos%20de%20ebastina%20e%20carebastina%2C%20enquanto%20a%20rifampicina%20pode%20diminuir%20os%20n%26%23xED%3Bveis%20de%20ebastina%20e%20carebastina%2C%20bem%20como%20interferir%20no%20resultado%20de%20testes%20al%26%23xE9%3Brgicos%20cut%26%23xE2%3Bneos.%3Cbr%3E%20A%20ebastina%20n%26%23xE3%3Bo%20apresenta%20intera%26%23xE7%3B%26%23xE3%3Bo%20com%20teofilina%2C%20varfarina%2C%20cimetidina%2C%20diazepam%2C%20ou%20%26%23xE1%3Blcool.%3Cbr%3E%20%3Cbr%3E%20Interfer%26%23xEA%3Bncia%20em%20exames%20laboratoriais%3Cbr%3E%20A%20ebastina%20pode%20interferir%20no%20resultado%20de%20testes%20al%26%23xE9%3Brgicos%20cut%26%23xE2%3Bneos%2C%20sendo%20prudente%20n%26%23xE3%3Bo%20realiz%26%23xE1%3B-los%20no%20per%26%23xED%3Bodo%20de%20cinco%20a%20sete%20dias%20ap%26%23xF3%3Bs%20a%20suspens%26%23xE3%3Bo%20do%20tratamento.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ERea%26%23xE7%3B%26%23xF5%3Bes%20adversas%20%2F%20efeitos%20colaterais%20de%20EBASTEL%3C%2Fh2%3E%0A%3Cp%3EOs%20eventos%20adversos%20da%20ebastina%20s%26%23xE3%3Bo%20apresentados%20em%20ordem%20de%20frequ%26%23xEA%3Bncia%20decrescente%20a%20seguir%3A%3Cbr%3E%20Comuns%20(frequentes)%20%26gt%3B%201%2F100%20e%20%26lt%3B%201%2F10%20(%26gt%3B%201%25%20e%20%26lt%3B%2010%25)%3A%20cefaleia%2C%20tontura%20e%20boca%20seca.%3Cbr%3E%20Incomuns%20(infrequentes)%2C%20%26gt%3B%201%2F1.000%20e%20%26lt%3B%201%2F100%20(%26gt%3B%200%2C1%25%20e%20%26lt%3B%201%25)%3A%20dor%20abdominal%2C%20dispepsia%2C%20epistaxe%2C%20rinite%2C%20sinusite%2C%20n%26%23xE1%3Busea%2C%20ins%26%23xF4%3Bnia%2C%20faringite%2C%20astenia.%3Cbr%3E%20Muito%20raros%2C%20%26lt%3B%201%2F10.000%20(%20%26lt%3B%200%2C01%25)%3A%20taquicardia%2C%20sonol%26%23xEA%3Bncia%2C%20nervosismo%2C%20urtic%26%23xE1%3Bria.%3Cbr%3E%20%3Cbr%3E%20Em%20casos%20de%20eventos%20adversos%2C%20notifique%20ao%20Sistema%20de%20Notifica%26%23xE7%3B%26%23xF5%3Bes%20em%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20%26%23x2013%3B%20NOTIVISA%2C%20dispon%26%23xED%3Bvel%20em%20www.anvisa.gov.br%2Fhotsite%2Fnotivisa%2Findex.htm%2C%20ou%20para%20a%20Vigil%26%23xE2%3Bncia%20Sanit%26%23xE1%3Bria%20Estadual%20ou%20Municipal.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EEBASTEL%20%26%23x2013%3B%20Posologia%3C%2Fh2%3E%0A%3Cp%3EPosologia%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20comprimido%20revestido%3A%20Adultos%20e%20crian%26%23xE7%3Bas%20maiores%20de%2012%20anos%3A%3Cbr%3E%20Rinite%20al%26%23xE9%3Brgica%3A%20um%20comprimido%20de%2010%20mg%2C%20administrado%20uma%20vez%20ao%20dia%2C%20%26%23xE9%3B%20eficaz%20no%20al%26%23xED%3Bvio%20dos%20sintomas%20da%20rinite%20al%26%23xE9%3Brgica.%20Em%20pacientes%20com%20sintomas%20mais%20intensos%2C%20incluindo%20rinite%20al%26%23xE9%3Brgica%20intermitente%2C%20a%20dose%20de%2020%20mg%20(dois%20comprimidos%20de%2010%20mg)%20administrada%20uma%20vez%20ao%20dia%20promove%20maior%20al%26%23xED%3Bvio%20dos%20sintomas.%3Cbr%3E%20Urtic%26%23xE1%3Bria%20idiop%26%23xE1%3Btica%3A%20um%20comprimido%20de%2010%20mg%2C%20administrado%20uma%20vez%20ao%20dia.%3Cbr%3E%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%3A%20Crian%26%23xE7%3Bas%20com%20idade%20entre%202%20e%205%20anos%3A%3Cbr%3E%202%2C5%20mL%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20(correspondente%20a%202%2C5%20mg%20de%20ebastina)%20administrados%20uma%20vez%20ao%20dia.%3Cbr%3E%20%3Cbr%3E%20%3Cbr%3E%20Crian%26%23xE7%3Bas%20com%20idade%20entre%206%20a%2011%20anos%3A%3Cbr%3E%205%20mL%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20(correspondente%20a%205%20mg%20de%20ebastina)%20administrados%20uma%20vez%20ao%20dia.%3Cbr%3E%20%3Cbr%3E%20Crian%26%23xE7%3Bas%20acima%20de%2012%20anos%20e%20adultos%3A%3Cbr%3E%2010%20mL%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20(correspondente%20a%2010%20mg%20de%20ebastina)%20administrados%20uma%20vez%20ao%20dia.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ser%20determinada%20pelo%20m%26%23xE9%3Bdico%20que%20prescreveu%20Ebastel%26%23xAE%3B%20(ebastina).%3Cbr%3E%20%3Cbr%3E%20Popula%26%23xE7%3B%26%23xF5%3Bes%20especiais%3A%3Cbr%3E%20Em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%2C%20n%26%23xE3%3Bo%20se%20deve%20exceder%20a%20dose%20de%2010%20mg.%3Cbr%3E%20Ebastel%26%23xAE%3B%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20(ebastina)%20vem%20acompanhado%20de%20uma%20seringa%20graduada%20e%20de%20um%20adaptador.%20Deve-seacoplar%20este%20adaptador%20%26%23xE0%3B%20boca%20do%20frasco%2C%20antes%20de%20administrar%20o%20produto.%20A%20fun%26%23xE7%3B%26%23xE3%3Bo%20deste%20adaptador%20%26%23xE9%3B%20permitir%20que%20o%20paciente%20consiga%20retirar%2C%20com%20o%20aux%26%23xED%3Blio%20da%20seringa%20graduada%2C%20a%20quantidade%20exata%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20a%20ser%20administrada%20mesmo%20quando%20o%20conte%26%23xFA%3Bdo%20do%20frasco%20estiver%20no%20final.%3Cbr%3E%20Ebastel%26%23xAE%3B%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20(ebastina)%20deve%20ser%20administrado%2C%20por%20via%20oral%2C%20com%20o%20aux%26%23xED%3Blio%20da%20seringa%20graduada%20que%20acompanha%20o%20medicamento.%20%3Cbr%3E%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20comprimido%20revestido%20n%26%23xE3%3Bo%20deve%20ser%20partido%20ou%20mastigado.%3Cbr%3E%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3ESuper%20dosagem%3C%2Fh2%3E%0A%3Cp%3EEm%20estudos%20realizados%20com%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20di%26%23xE1%3Bria%20de%20doses%20%26lt%3B%20100%20mg%2C%20n%26%23xE3%3Bo%20foram%20observados%20sinais%20ou%20sintomas%20significantes.%20N%26%23xE3%3Bo%20existe%20ant%26%23xED%3Bdoto%20espec%26%23xED%3Bfico%20para%20a%20ebastina.%20Em%20caso%20de%20superdosagem%2C%20deve-se%20realizar%20lavagem%20g%26%23xE1%3Bstrica%2C%20monitoriza%26%23xE7%3B%26%23xE3%3Bo%20das%20fun%26%23xE7%3B%26%23xF5%3Bes%20vitais%2C%20incluindo%20eletrocardiograma%20e%20tratamento%20dos%20sintomas%20observados.%3Cbr%3E%20Em%20caso%20de%20intoxica%26%23xE7%3B%26%23xE3%3Bo%20ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3ECaracteristicas%20farmalogicas%3C%2Fh2%3E%0A%3Cp%3EFarmacodin%26%23xE2%3Bmica%3Cbr%3E%20A%20ebastina%20determina%20inibi%26%23xE7%3B%26%23xE3%3Bo%20r%26%23xE1%3Bpida%20e%20de%20longa%20dura%26%23xE7%3B%26%23xE3%3Bo%20dos%20efeitos%20induzidos%20pela%20histamina%2C%20al%26%23xE9%3Bm%20de%20possuir%20forte%20afinidade%20pelos%20receptores%20H1.%20A%20ebastina%20e%20seus%20metab%26%23xF3%3Blitos%20n%26%23xE3%3Bo%20atravessam%20a%20barreira%20hematoencef%26%23xE1%3Blica%20ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral%2C%20o%20que%20explica%20o%20pequeno%20efeito%20sedativo%20encontrado%20nos%20estudos%20que%20avaliaram%20os%20efeitos%20da%20ebastina%20sobre%20o%20sistema%20nervoso%20central%20(SNC).%20Dados%20in%20vitro%20e%20in%20vivodemonstram%20que%20a%20ebastina%20exerce%20potente%20antagonismo%20dos%20receptores%20H1%2C%20de%20longa%20dura%26%23xE7%3B%26%23xE3%3Bo%20e%20altamente%20seletivo%2C%20n%26%23xE3%3Bo%20apresentando%20efeitos%20sobre%20o%20SNC%2C%20ou%20efeitos%20anticolin%26%23xE9%3Brgicos.%20Dados%20in%20vitro%20mostraram%20que%20a%20ebastina%20inibe%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20de%20prostaglandinas%20e%20leucotrienos%20induzida%20por%20IgE%2C%20bem%20como%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20de%20fator%20estimulador%20de%20col%26%23xF4%3Bnias%20de%20macr%26%23xF3%3Bfagos%20e%20granul%26%23xF3%3Bcitos%20(GM-CSF).%20A%20ebastina%20reduz%20tamb%26%23xE9%3Bm%20a%20libera%26%23xE7%3B%26%23xE3%3Bo%20de%20GM-%20CSF%20e%20de%20eosin%26%23xF3%3Bfilos%20nas%20secre%26%23xE7%3B%26%23xF5%3Bes%20nasais.%3Cbr%3E%20Estudos%20relatados%20de%20indu%26%23xE7%3B%26%23xE3%3Bo%20de%20p%26%23xE1%3Bpula%20por%20histamina%20mostraram%20que%20a%20ebastina%20apresenta%20efeito%20anti-histam%26%23xED%3Bnicoestat%26%23xED%3Bstica%20e%20clinicamente%20significante%2C%20com%20in%26%23xED%3Bcio%20de%20a%26%23xE7%3B%26%23xE3%3Bo%20ap%26%23xF3%3Bs%20uma%20hora%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral%20e%20com%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%2048%20horas.%20Observou-se%20tamb%26%23xE9%3Bm%20que%2C%20com%20a%20interrup%26%23xE7%3B%26%23xE3%3Bo%20da%20administra%26%23xE7%3B%26%23xE3%3Bo%20da%20ebastina%20ap%26%23xF3%3Bs%20tratamento%20durante%20cinco%20dias%2C%20a%20atividade%20anti-histam%26%23xED%3Bnicas%20persiste%20por%20mais%20do%20que%2072%20horas.%20Esta%20atividade%20%26%23xE9%3B%20devida%20aos%20n%26%23xED%3Bveis%20plasm%26%23xE1%3Bticos%20do%20principal%20metab%26%23xF3%3Blito%20%26%23xE1%3Bcido%20ativo%2C%20a%20carebastina.%20Ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xF5%3Bes%20repetidas%2C%20a%20inibi%26%23xE7%3B%26%23xE3%3Bo%20dos%20receptores%20perif%26%23xE9%3Bricos%20permanece%20em%20n%26%23xED%3Bvel%20constante%2C%20sem%20taquifilaxia.%20Estes%20resultados%20sugerem%20que%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20da%20dose%20di%26%23xE1%3Bria%20m%26%23xED%3Bnima%20de%2010%20mg%20de%20ebastina%20produz%20inibi%26%23xE7%3B%26%23xE3%3Bo%20r%26%23xE1%3Bpida%2C%20intensa%20e%20de%20longa%20dura%26%23xE7%3B%26%23xE3%3Bo%20dos%20receptores%20histam%26%23xED%3Bnicos%20H1%20perif%26%23xE9%3Bricos.%3Cbr%3E%20Em%20estudos%20nos%20quais%20a%20seda%26%23xE7%3B%26%23xE3%3Bo%20foi%20avaliada%20por%20meio%20de%2C%20eletroencefalograma%2C%20desempenho%20cognitivo%2C%20testes%20de%20coordena%26%23xE7%3B%26%23xE3%3Bo%20visual-motora%20e%20estimativas%20subjetivas%2C%20n%26%23xE3%3Bo%20houve%20aumento%20significante%20da%20seda%26%23xE7%3B%26%23xE3%3Bo%20na%20dose%20recomendada.%20Estes%20dados%20s%26%23xE3%3Bo%20compat%26%23xED%3Bveis%20com%20os%20resultados%20dos%20estudos%20cl%26%23xED%3Bnicos%20duplo-cegos%20nos%20quais%20a%20incid%26%23xEA%3Bncia%20de%20seda%26%23xE7%3B%26%23xE3%3Bo%20com%20ebastina%20mostrou-se%20compar%26%23xE1%3Bvel%20ao%20placebo.%3Cbr%3E%20Nos%20estudos%20cl%26%23xED%3Bnicos%20realizados%20em%20adultos%20e%20crian%26%23xE7%3Bas%20n%26%23xE3%3Bo%20se%20observaram%20efeitos%20card%26%23xED%3Bacos%20causados%20pela%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20ebastina%20nas%20doses%20recomendadas%2C%20incluindo%20prolongamento%20do%20intervalo%20QT.%3Cbr%3E%20Com%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20da%20dose%20de%2060%20mg%2Fdia%20de%20ebastina%2C%20n%26%23xE3%3Bo%20se%20observou%20efeito%20sobre%20o%20intervalo%20QT.%20Com%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20da%20dose%20de%20100%20mg%2Fdia%2C%20observou-se%20um%20aumento%20estatisticamente%20significante%20de%2010%20mseg%20(2%2C7%25)%2C%20que%20n%26%23xE3%3Bo%20foi%20contudo%2C%20clinicamente%20significante.%20Ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20dose%20di%26%23xE1%3Bria%20de%2015%20mg%20de%20ebastina%20em%20crian%26%23xE7%3Bas%20com%20idade%20entre%20seis%20e%2011%20anos%2C%20durante%206%20dias%2C%20n%26%23xE3%3Bo%20foram%20observadas%20diferen%26%23xE7%3Bas%20no%20intervalo%20QT%20m%26%23xE9%3Bdio%2C%20entre%20os%20grupos%20tratados%20com%20ebastina%2C%20ou%20placebo%2C%20no%20primeiro%20e%20sexto%20dias%20do%20tratamento.%3Cbr%3E%20%3Cbr%3E%20Farmacocin%26%23xE9%3Btica%3Cbr%3E%20Ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral%2C%20a%20ebastina%20%26%23xE9%3B%20rapidamente%20absorvida%2C%20sofrendo%20extenso%20metabolismo%20de%20primeira%20passagem.%20A%20ebastina%20%26%23xE9%3B%20quase%20completamente%20convertida%20a%20seu%20metab%26%23xF3%3Blito%20%26%23xE1%3Bcido%20farmacologicamente%20ativo%2C%20a%20carebastina.%3Cbr%3E%20Ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20dose%20%26%23xFA%3Bnica%20de%2010%20mg%20de%20ebastina%2C%20as%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20m%26%23xE1%3Bximas%20de%2080%20a%20100%20ng%2FmL%20do%20metab%26%23xF3%3Blito%20ocorrem%20dentro%20de%202%2C6%20a%204%20horas.%20A%20meia-vida%20do%20metab%26%23xF3%3Blito%20%26%23xE1%3Bcido%20%26%23xE9%3B%20de%2015-19%20horas%2C%20sendo%20que%2066%25%20do%20f%26%23xE1%3Brmaco%20%26%23xE9%3B%20excretado%20na%20urina%2C%20principalmente%20na%20forma%20de%20metab%26%23xF3%3Blito%20conjugado.%20Ap%26%23xF3%3Bs%20administra%26%23xE7%3B%26%23xF5%3Bes%20repetidas%20de%2010%20mg%20de%20ebastina%2C%20uma%20vez%20ao%20dia%2C%20o%20estado%20de%20equil%26%23xED%3Bbrio%20%26%23xE9%3B%20atingido%20em%20tr%26%23xEA%3Bs%20a%20cinco%20dias%2C%20com%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20m%26%23xE1%3Bximas%2C%20variando%20entre%20130%20a%20160%20ng%2FmL.%3Cbr%3E%20Os%20par%26%23xE2%3Bmetros%20farmacocin%26%23xE9%3Bticos%20da%20carebastina%20se%20mostraram%20linear%20e%20dose%20independentes%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%205%20e%2010%20mg%20de%20ebastina%20na%20forma%20de%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20com%20obten%26%23xE7%3B%26%23xE3%3Bo%20de%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20m%26%23xE1%3Bximas%20de%20108%20e%20209%20ng%2FmL%20de%20carebastina%20dentro%20de%202%2C8%20e%203%2C4%20horas%2C%20respectivamente.%20A%20meia-vida%20de%20elimina%26%23xE7%3B%26%23xE3%3Bo%20da%20carebastina%20variou%20entre%2010%20e%2014%20horas.%3Cbr%3E%20Os%20estudos%20in%20vitro%20com%20microssomas%20hep%26%23xE1%3Bticos%20humanos%20mostraram%20que%20a%20ebastina%20%26%23xE9%3B%20metabolizada%20em%20desalquilebastina%20via%20CYP3A4%20e%20em%20hidroxiebastina%20via%20CYP2J2%2C%20sendo%20esta%20%26%23xFA%3Bltima%20convertida%20em%20carebastina%20por%20carboxila%26%23xE7%3B%26%23xE3%3Bo%2C%20via%20CYP3A4%20e%20CYP2J2.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20simult%26%23xE2%3Bnea%20de%20ebastina%20com%20cetoconazol%2C%20itraconazol%20ou%20eritromicina%20(ambos%20inibidores%20da%20CYP3A4)%20em%20volunt%26%23xE1%3Brios%20sadios%20foi%20associada%20ao%20aumento%20significante%20das%20concentra%26%23xE7%3B%26%23xF5%3Bes%20plasm%26%23xE1%3Bticas%20de%20ebastina%20e%20carebastina.%20O%20aumento%20do%20n%26%23xED%3Bvel%20s%26%23xE9%3Brico%20de%20carebastina%20associado%20ao%20uso%20de%20itraconazol%20n%26%23xE3%3Bo%20%26%23xE9%3B%20suficiente%20para%20potencializar%20o%20efeito%20cl%26%23xED%3Bnico%20anti-histam%26%23xED%3Bnico.%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20da%20ebastina%20com%20rifampicina%20em%20volunt%26%23xE1%3Brios%20sadios%20diminuiu%20os%20n%26%23xED%3Bveis%20de%20ebastina%20e%20carebastina.%20(vide%20%26%23x93%3BINTERA%26%23xC7%3B%26%23xD5%3BES%20MEDICAMENTOSAS%26%23x94%3B).%3Cbr%3E%20A%20liga%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3Bs%20prote%26%23xED%3Bnas%20plasm%26%23xE1%3Bticas%2C%20tanto%20da%20ebastina%2C%20quanto%20da%20carebastina%20%26%23xE9%3B%20alta%2C%20%26gt%3B%2095%25.%3Cbr%3E%20N%26%23xE3%3Bo%20foram%20observadas%20altera%26%23xE7%3B%26%23xF5%3Bes%20estatisticamente%20significantes%20da%20farmacocin%26%23xE9%3Btica%20da%20ebastina%20em%20idosos%2C%20em%20compara%26%23xE7%3B%26%23xE3%3Bo%20%26%23xE0%3B%20farmacocin%26%23xE9%3Btica%2C%20em%20volunt%26%23xE1%3Brios%20adultos%20jovens.%3Cbr%3E%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20ebastina%20com%20alimentos%20n%26%23xE3%3Bo%20modifica%20seus%20efeitos.%20A%20ebastina%20n%26%23xE3%3Bo%20apresenta%20intera%26%23xE7%3B%26%23xE3%3Bo%20com%20o%20%26%23xE1%3Blcool.%3Cbr%3E%20A%20meia-vida%20de%20elimina%26%23xE7%3B%26%23xE3%3Bo%20da%20carebastina%20aumentou%20para%2023%20%26%23x96%3B%2026%20horas%20e%2027%20horas%2C%20respectivamente%2C%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20renal%20e%20em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EResultados%20de%20eficacia%3C%2Fh2%3E%0A%3Cp%3E%26%23x95%3B%20Rinite%20al%26%23xE9%3Brgica%20intermitente%3Cbr%3E%20Em%20um%20estudo%20duplo-cego%2C%20placebo-controlado%2C%20randomizado%20e%20de%20grupos%20paralelos%2C%20565%20pacientes%20com%20rinite%20al%26%23xE9%3Brgica%20intermitente%2C%20entre%2012%20e%2070%20anos%20de%20idade%2C%20receberam%20ebastina%20nas%20doses%20de%2010%20e%2020%20mg%2C%20loratadina%2C%20na%20dose%20de%2010%20mg%2C%20ou%20placebo%20uma%20vez%20ao%20dia%20durante%20quatro%20semanas.%20Os%20pacientes%20registraram%20os%20escores%20para%20rinorreia%2C%20congest%26%23xE3%3Bo%20nasal%20%5Boutras%20anormalidades%20da%20respira%26%23xE7%3B%26%23xE3%3Bo%5D%2C%20espirros%2C%20prurido%20e%20sintomas%20oculares%20pela%20manh%26%23xE3%3B%20e%20%26%23xE0%3B%20noite.%20A%20ebastina%20na%20dose%20de%2020%20mg%20promoveu%20redu%26%23xE7%3B%26%23xF5%3Bes%20significantemente%20maiores%20que%20a%20loratadina%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20basal%20ao%20longo%20de%20todo%20o%20per%26%23xED%3Bodo%20de%20tratamento%20no%20escore%20total%20de%20sintomas%20di%26%23xE1%3Brios%20(42%2C5%25%20vs%2036%2C3%25)%20e%20matinais%20(40%2C3%25vs%2031%2C3%25)%2C%20al%26%23xE9%3Bm%20de%20redu%26%23xE7%3B%26%23xF5%3Bes%20significantemente%20superiores%20nos%20itens%20individuais%3A%20rinorreia%2C%20congest%26%23xE3%3Bo%20nasal%20e%20espirro%20(p%26lt%3B0%2C05)%20.%20Os%20efeitos%20da%20ebastina%20na%20dose%20de%2010%20mg%20foram%20semelhantes%20aos%20efeitos%20da%20loratadina%2010%20mg%20e%20superiores%20aos%20efeitos%20do%20placebo%201%20.%20Resultados%20semelhantes%20foram%20obtidos%20por%20Hampel%20Jr%20e%20cols%2C%20que%20em%20um%20estudo%20duplo-cego%20randomizado%20de%204%20semanas%20(N%3D749)%2C%20compararam%20ebastina%2020%20mg%2C%20ebastina%2010%20mg%20%2C%20loratadina%2010%20mg%20e%20placebo.%20A%20dose%20de%2020%20mg%20foi%20superior%20%26%23xE0%3B%20loratadina%20e%20ao%20placebo%20na%20redu%26%23xE7%3B%26%23xE3%3Bo%20dos%20escores%20de%20sintomas%20di%26%23xE1%3Brios%20e%20matinais%2C%20e%20a%20ebastina%2010%20mg%20foi%20superior%20%26%23xE0%3B%20loratadina%20e%20ao%20placebo%20na%20redu%26%23xE7%3B%26%23xE3%3Bo%20dos%20sintomas%20matinais%20de%20rinite.%20Outro%20estudo%20duplo-cego%20(N%3D%20343)%2C%20que%20comparou%20doses%20di%26%23xE1%3Brias%20de%20cetirizina%2010%20mg%2C%20ebastina%2010%20mg%20e%20ebastina%2020%20mg%20%2C%20mostrou%20que%20os%20tr%26%23xEA%3Bs%20tratamentos%20foram%20eficazes%20no%20controle%20dos%20sintomas%20de%20rinite%2C%20sendo%20que%20a%20ebastina%20na%20dose%20de%2020%20mg%20foi%20mais%20eficaz%20que%20a%20de%2010%20mg%20em%20casos%20com%20sintomatologia%20mais%20intensa.%20A%20efic%26%23xE1%3Bcia%20da%20ebastina%20tamb%26%23xE9%3Bm%20foi%20demonstrada%20em%20crian%26%23xE7%3Bas%2C%20com%20rinite%20al%26%23xE9%3Brgica%20intermitente%2C%20em%20um%20estudo%20duplo-cego%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%20tr%26%23xEA%3Bs%20semanas%20no%20qual%20173%20crian%26%23xE7%3Bas%20entre%20seis%20e%2011%20anos%20de%20idade%20apresentaram%20melhora%20significantemente%20maior%20no%20escore%20global%20de%20sintomas%20de%20alergia%2C%20com%20a%20ebastina%20na%20dose%20de%205%20mg%20ao%20dia%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20placebo%20(p%20%3D%200%2C049)%202.%3Cbr%3E%20%3Cbr%3E%20%26%23x95%3BRinite%20al%26%23xE9%3Brgica%20persistente%3Cbr%3E%20Dois%20estudos%20em%20pacientes%20com%20rinite%20al%26%23xE9%3Brgica%20persistente%20compararam%20a%20ebastina%20na%20dose%20de%2020%20mg%20com%20o%20placebo%20em%20pacientes%2C%20com%20idade%20superior%20a%2012%20anos%20de%20idade.%20Nesses%20estudos%2C%20os%20pacientes%20apresentavam%20um%20escore%20total%20de%20sintomas%20de%20rinite%20(rinorreia%2C%20espirros%20e%20prurido%20nasal)%20m%26%23xED%3Bnimo%20de%2032%20de%20poss%26%23xED%3Bveis%2063%20pontos%20ao%20longo%20do%20per%26%23xED%3Bodo%20de%20rastreamento%20de%20tr%26%23xEA%3Bs%20dias%20mais%20a%20manh%26%23xE3%3B%20do%20dia%20basal%2C%20bem%20como%20um%20teste%20de%20pele%20positivo%20para%20um%20al%26%23xE9%3Brgeno%20e%20um%20esfrega%26%23xE7%3Bo%20nasal%2C%20para%20eosin%26%23xF3%3Bfilos%20positivos.%20No%20primeiro%20estudo%2C%20no%20qual%20223%20pacientes%20foram%20inclu%26%23xED%3Bdos%20na%20an%26%23xE1%3Blise%20de%20efic%26%23xE1%3Bcia%2C%20a%20redu%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdia%20no%20escore%20total%20de%20sintomas%2C%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20basal%2C%20foi%20de%20%26%23x96%3B%202%2C39%2C%26%23x96%3B2%2C23%20e%20%26%23x96%3B1%2C65para%20ebastina%2010%20mg%20duas%20vezes%20ao%20dia%2C%20ebastina%2020%20mg%20uma%20vez%20ao%20dia%20e%20placebo%2C%20respectivamente.%20Ambos%20os%20esquemas%20posol%26%23xF3%3Bgicos%20tiveram%20efic%26%23xE1%3Bcia%20superior%20ao%20placebo%20ao%20final%20de%203%20semanas.%20No%20segundo%20estudo%2C%20no%20qual%20194%20pacientes%20foram%20considerados%20na%20an%26%23xE1%3Blise%20de%20efic%26%23xE1%3Bcia%2C%20a%20ebastina%2020%20mg%20reduziu%20significantemente%20os%20sintomas%20de%20rinite%20em%20rela%26%23xE7%3B%26%23xE3%3Bo%20ao%20placebo%3A%20as%20altera%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdias%20ajustadas%20no%20%26%23x93%3BPerennial%20Index%26%23x94%3B%20foram%20%26%23x96%3B2%2C06%20e%20%26%23x96%3B1%2C51%20para%20ebastina%2020%20mg%20e%20placebo%2C%20respectivamente%20(p%20%3D%200%2C024)%203.%20Um%20estudo%20multic%26%23xEA%3Bntrico%2C%20randomizado%20(N%3D317)%2C%20com%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%204%20semanas%2C%20demonstrou%20a%20efic%26%23xE1%3Bcia%20da%20ebastina%20no%20tratamento%20da%20rinite%20al%26%23xE9%3Brgica%20persistente%2C%20nas%20doses%20de%2010%20e%2020%20mg%2C%20sendo%20ambas%20igualmente%20eficazes%20e%20superiores%20%26%23xE0%3B%20loratadina%2010%20mg%20na%20redu%26%23xE7%3B%26%23xE3%3Bo%20do%20%26%23x201C%3BPerennial%20Index%26%23x201D%3B%2C%20com%20altera%26%23xE7%3B%26%23xF5%3Bes%20m%26%23xE9%3Bdias%20de%20-2%2C02%20para%20ebastina%2010mg%20(p%26lt%3B0%2C05%20vs%20loratadina)%2C%20-2%2C12%20para%20ebastina%2020%20mg%20(p%26lt%3B0%2C01%20vs%20loratadina)%20e%20-1%2C50%20para%20loratadina%2010%20mg.%3Cbr%3E%20%3Cbr%3E%20%26%23x95%3BUrtic%26%23xE1%3Bria%20idiop%26%23xE1%3Btica%3Cbr%3E%20A%20efic%26%23xE1%3Bcia%20da%20ebastina%20em%20pacientes%20com%20urtic%26%23xE1%3Bria%20idiop%26%23xE1%3Btica%20foi%20avaliada%20em%20dois%20estudos%20randomizados%2C%20duplo-cegos%2C%20controlados.%20Em%20um%20estudo%20duplo-cego%20que%20incluiu%20204%20pacientes%2C%20com%20dura%26%23xE7%3B%26%23xE3%3Bo%20de%202%20semanas%2C%20Peyri%20e%20cols.%20demonstraram%20que%20ebastina%20na%20dose%20de%2010%20mg%20reduziu%20significantemente%20o%20prurido%2C%20o%20n%26%23xFA%3Bmero%20e%20o%20tamanho%20das%20p%26%23xE1%3Bpulas%20em%20compara%26%23xE7%3B%26%23xE3%3Bo%20ao%20placebo.%20A%20efic%26%23xE1%3Bcia%20global%20considerada%20pelos%20pacientes%20e%20m%26%23xE9%3Bdicos%20como%20boa%2Fmoderada%20foi%20significantemente%20maior%20com%20ebastina%20que%20com%20placebo%20(80%26%23x96%3B83%25%20vs%2051%26%23x96%3B55%25)%20(p%26lt%3B0%2C001).%20No%20segundo%20estudo%20(N%3D211)%2C%20com%2012%20semanas%20de%20dura%26%23xE7%3B%26%23xE3%3Bo%2C%20a%20efic%26%23xE1%3Bcia%20da%20ebastina%2010%20mg%20foi%20semelhante%20%26%23xE0%3B%20da%20terbinafina%20na%20dose%20de%2060%20mg%20administrada%20duas%20vezes%20ao%20dia%2C%20no%20al%26%23xED%3Bvio%20dos%20sintomas%20e%20na%20avalia%26%23xE7%3B%26%23xE3%3Bo%20global%20do%20m%26%23xE9%3Bdico%20e%20do%20paciente%20e%20ambos%20os%20medicamentos%20foram%20superiores%20ao%20placebo%204.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EUsos%20em%20idosos%2C%20crian%26%23xE7%3Bas%20e%20em%20outros%20grupos%20de%20risco%3C%2Fh2%3E%0A%3Cp%3EInforma%26%23xE7%3B%26%23xE3%3Bo%20n%26%23xE3%3Bo%20dispon%26%23xED%3Bvel%20para%20esta%20bula.%3C%2Fp%3E%0A%20%20%20%20%20%20%20%20%3Camp-ad%20width%3D%22300%22%20height%3D%22250%22%20type%3D%22adsense%22%20data-ad-client%3D%22ca-pub-2735105532917738%22%20data-ad-slot%3D%222092927135%22%20data-auto-format%3D%22auto%22%20data-full-width-responsive%3D%22true%22%3E%0A%20%20%20%20%20%20%20%20%20%20%20%20%3Cdiv%20overflow%3E%3C%2Fdiv%3E%0A%20%20%20%20%20%20%20%20%3C%2Famp-ad%3E%0A%3Ch2%3EArmazenagem%3C%2Fh2%3E%0A%3Cp%3EEbastel%26%23xAE%3B%20(ebastina)%20comprimidos%20deve%20ser%20mantido%20em%20sua%20embalagem%20original%2C%20conservado%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC)%2C%20protegido%20da%20luz%20e%20umidade.%3Cbr%3E%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20solu%26%23xE7%3B%26%23xE3%3Bo%20oral%20deve%20ser%20mantido%20em%20sua%20embalagem%20original%2C%20conservado%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC)%2C%20protegido%20da%20luz.%3Cbr%3E%20Desde%20que%20observados%20os%20devidos%20cuidados%20de%20conserva%26%23xE7%3B%26%23xE3%3Bo%2C%20o%20prazo%20de%20validade%20do%20produto%20%26%23xE9%3B%20de%2024%20meses%2C%20contados%20a%20partir%20da%20data%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20impressa%20em%20sua%20embalagem%20externa.%3Cbr%3E%20%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vide%20embalagem.%3Cbr%3E%20N%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido.%20Guarde-o%20em%20sua%20embalagem%20original.%3Cbr%3E%20%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20um%20comprimido%20circular%20revestido%2C%20biconvexo%2C%20sem%20Branco.%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20l%26%23xED%3Bquido%20l%26%23xED%3Bmpido%2C%20incolor%2C%20isento%20de%20sedimenta%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20%3Cbr%3E%20Antes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%3Cbr%3E%20Todo%20medicamento%20deve%20ser%20mantido%20fora%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EDizeres%20legais%3C%2Fh2%3E%0A%3Cp%3EMS%20%26%23x2013%3B%201.0043.0760%3Cbr%3E%20Farm.%20Resp.%3A%20Dra.%20S%26%23xF4%3Bnia%20Albano%20Badar%26%23xF3%3B%20%26%23x2013%3B%20CRF-SP%2019.258%3Cbr%3E%20%3Cbr%3E%20Marca%20registrada%20sob%20licen%26%23xE7%3Ba%20de%3A%3Cbr%3E%20ALMIRALL%20S.A.%3Cbr%3E%20Barcelona%20%26%23x96%3B%20Espanha%3Cbr%3E%20%3Cbr%3E%20Registrado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Av.%20Vereador%20Jos%26%23xE9%3B%20Diniz%2C%203.465%20%26%23x2013%3B%20S%26%23xE3%3Bo%20Paulo%20%26%23x2013%3B%20SP%3Cbr%3E%20CNPJ%3A%2061.190.096%2F0001-92%3Cbr%3E%20Ind%26%23xFA%3Bstria%20Brasileira%3Cbr%3E%20%3Cbr%3E%20Solu%26%23xE7%3B%26%23xE3%3Bo%20Oral%3A%3Cbr%3E%20Fabricado%20por%3A%3Cbr%3E%20EUROFARMA%20LABORAT%26%23xD3%3BRIOS%20S.A.%3Cbr%3E%20Rod.%20Pres.%20Castelo%20Branco%2C%20km%2035%2C6%20%26%23x96%3B%20Itapevi%20%26%23x96%3BSP%3Cbr%3E%20%3Cbr%3E%20LOGO%20CENTRAL%20DE%20ATENDIMENTO%20EUROFARMA%20COM%20TEL%200800%20704%203876.%3Cbr%3E%20%3Cbr%3E%20Venda%20sob%20prescri%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica.%3Cbr%3E%20%3Cbr%3E%20Refer%26%23xEA%3Bncias%20bibliogr%26%23xE1%3Bficas%3Cbr%3E%201Ratner%20PH%2C%20Lim%20JC%2C%20Georges%20GC%2C%20and%20the%20Ebastine%20Study%20Group.%20Comparison%20of%20once-daily%20ebastine%2020%20mg%2C%20ebastine%2010%20mg%2C%20loratadine%2010%20mg%2C%20and%20placebo%20in%20the%20treatment%20of%20seasonal%20allergic%20rhinitis.%20Allergy%20Clin%20Immunol2000%3B105%3A1101-7.%3Cbr%3E%20%3Cbr%3E%202Ostrom%20N%2C%20Welch%20M%2C%20Morris%20R%2C%20et%20al.%20Evaluation%20of%20ebastine%20(Eba)%2C%20a%20new%20non-sedating%20antihistamine%20in%20children%20with%20seasonal%20allergic%20rhinitis%20(SAR)%20%5Babstract%20no.%20261586%5D.%20J%20Allergy%20Clin%20Immunol%201994%3B%2093%20(1%20Pt%202)%3A%3Cbr%3E%20163APUD%20Hurst%20M%20%26amp%3B%20Spencer%20CM.%20Ebastine%2C%20An%20Update%20of%20its%20Use%20in%20Allergic%20Disorders.%20Drugs%202000%3B%2059%3A%20981-%201006.%3Cbr%3E%20%3Cbr%3E%203Luria%20X.%20Comparative%20Clinical%20Studies%20with%20Ebastine.%20Efficacy%20and%20Tolerability.%20Drug%20Safety%201999%3B%2021%20Suppl.%201%3A63-7.%3Cbr%3E%20%3Cbr%3E%204Sastre%20J.%20Ebastine%20in%20allergic%20rhinitis%20and%20chronic%20idiopathic%20urticaria.%20Allergy%202008%3A%2063%20(89)%3A%201%26%23x96%3B20.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EEBASTEL%20%26%23x2013%3B%20Bula%20para%20o%20paciente%3C%2Fh2%3E%0A%3Cp%3E1.PARA%20QUE%20ESTE%20MEDICAMENTO%20%26%23xC9%3B%20INDICADO%3F%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20indicado%20para%20o%20tratamento%20sintom%26%23xE1%3Btico%20da%20rinite%20al%26%23xE9%3Brgica%20intermitente%20e%20da%20rinite%20al%26%23xE9%3Brgica%20persistente%2C%20associadas%20ou%20n%26%23xE3%3Bo%20%26%23xE0%3B%20conjuntivite%20al%26%23xE9%3Brgica.%20Ebastel%26%23xAE%3B%20(ebastina)%20tamb%26%23xE9%3Bm%20est%26%23xE1%3B%20indicado%20no%20tratamento%20da%20urtic%26%23xE1%3Bria.%3Cbr%3E%20%3Cbr%3E%202.%20COMO%20ESTE%20MEDICAMENTO%20FUNCIONA%3F%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20um%20medicamento%20anti-histam%26%23xED%3Bnico%20que%20reduz%20os%20sintomas%20de%20alergia%20por%20prevenir%20os%20efeitos%20da%20histamina%2C%20uma%20subst%26%23xE2%3Bncia%20produzida%20pelo%20organismo.%20Os%20sintomas%20de%20alergia%20na%20rinite%20incluem%20secre%26%23xE7%3B%26%23xE3%3Bo%20nasal%2C%20espirros%2C%20coceira%20e%20entupimento%20nasal.%20Nos%20olhos%2C%20podem%20ocorrer%20tamb%26%23xE9%3Bm%20vermelhid%26%23xE3%3Bo%2C%20lacrimejamento%20e%20coceira.%20A%20urtic%26%23xE1%3Bria%20caracteriza-se%20pela%20presen%26%23xE7%3Ba%20de%20les%26%23xF5%3Bes%20avermelhadas%20e%20sobrelevadas%20na%20pele%2C%20que%20co%26%23xE7%3Bam.%3Cbr%3E%20O%20tempo%20para%20o%20in%26%23xED%3Bcio%20da%20a%26%23xE7%3B%26%23xE3%3Bo%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo%20por%20via%20oral%2C%20varia%20de%201%20(uma)%20a%203%20(tr%26%23xEA%3Bs)%20horas%2C%20com%20efetividade%20m%26%23xE1%3Bxima%20observada%20em%203%20(tr%26%23xEA%3Bs)%20a%2012%20(doze)%20horas.%3Cbr%3E%20%3Cbr%3E%203.QUANDO%20N%26%23xC3%3BO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Voc%26%23xEA%3B%20n%26%23xE3%3Bo%20deve%20utilizar%20Ebastel%26%23xAE%3B%20(ebastina)%20se%20apresentar%20hipersensibilidade%20(alergia)%20%26%23xE0%3B%20ebastina%2C%20ou%20a%20qualquer%20um%20dos%20componentes%20da%20formula%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20menores%20de%2012%20anos.%3Cbr%3E%20Este%20medicamento%20%26%23xE9%3B%20contraindicado%20para%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20grave.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20gr%26%23xE1%3Bvidas%20sem%20orienta%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20ou%20do%20cirurgi%26%23xE3%3Bo-%20dentista.%3Cbr%3E%20%3Cbr%3E%204.O%20QUE%20DEVO%20SABER%20ANTES%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20n%26%23xE3%3Bo%20deve%20ser%20administrado%20em%20caso%20de%20doen%26%23xE7%3Ba%20al%26%23xE9%3Brgica%20aguda%20que%20necessite%20de%20aten%26%23xE7%3B%26%23xE3%3Bo%20urgente%20(por%20exemplo%3A%20anafilaxia)%2C%20j%26%23xE1%3B%20que%20o%20efeito%20terap%26%23xEA%3Butico%20aparece%201%20a%203%20horas%20ap%26%23xF3%3Bs%20a%20administra%26%23xE7%3B%26%23xE3%3Bo.%3Cbr%3E%20Como%20acontece%20com%20outros%20anti-histam%26%23xED%3Bnicos%2C%20deve-se%20ter%20cautela%20com%20o%20uso%20da%20ebastina%20por%20pacientes%20que%20apresentam%20baixas%20concentra%26%23xE7%3B%26%23xF5%3Bes%20de%20pot%26%23xE1%3Bssio%20no%20sangue%2C%20uma%20altera%26%23xE7%3B%26%23xE3%3Bo%20no%20eletrocardiograma%20conhecida%20como%20s%26%23xED%3Bndrome%20do%20intervalo%20QT%20longo%20e%20por%20pacientes%20que%20estejam%20em%20tratamento%20com%20f%26%23xE1%3Brmacos%20que%20causem%20altera%26%23xE7%3B%26%23xF5%3Bes%20eletrocardiogr%26%23xE1%3Bficas%2C%20ou%20inibam%20a%20enzima%20hep%26%23xE1%3Btica%20CYP3A4%2C%20tais%20como%20alguns%20antif%26%23xFA%3Bngicos%20(cetoconazol%2C%20por%20exemplo)%20e%20alguns%20antibi%26%23xF3%3Bticos%20(como%20a%20eritromicina).%3Cbr%3E%20Voc%26%23xEA%3B%20deve%20ter%20cautela%20na%20utiliza%26%23xE7%3B%26%23xE3%3Bo%20de%20Ebastel%26%23xAE%3B%20(ebastina)%20se%20for%20portador%20de%20problemas%20nos%20rins%20ou%20no%20f%26%23xED%3Bgado.%3Cbr%3E%20%3Cbr%3E%20Gravidez%20e%20lacta%26%23xE7%3B%26%23xE3%3Bo%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20que%20estejam%20amamentando.%3Cbr%3E%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%20a%20ocorr%26%23xEA%3Bncia%20de%20gravidez%20na%20vig%26%23xEA%3Bncia%20do%20tratamento%2C%20ou%20ap%26%23xF3%3Bs%20seu%20t%26%23xE9%3Brmino.%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%20se%20est%26%23xE1%3B%20amamentando.%3Cbr%3E%20%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20utilizado%20por%20mulheres%20gr%26%23xE1%3Bvidas%20sem%20orienta%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica%20ou%20do%20cirurgi%26%23xE3%3Bo-dentista.%3Cbr%3E%20%3Cbr%3E%20A%20administra%26%23xE7%3B%26%23xE3%3Bo%20de%20Ebastel%26%23xAE%3B%20(ebastina)%20com%20alimentos%20n%26%23xE3%3Bo%20modifica%20seus%20efeitos.%20A%20ebastina%20n%26%23xE3%3Bo%20apresenta%20intera%26%23xE7%3B%26%23xE3%3Bo%20com%20o%20%26%23xE1%3Blcool.%3Cbr%3E%20%3Cbr%3E%20Intera%26%23xE7%3B%26%23xF5%3Bes%20medicamentosas%3Cbr%3E%20A%20ebastina%20pode%20potencializar%20o%20efeito%20de%20outros%20anti-histam%26%23xED%3Bnicos.%20Foram%20observadas%20intera%26%23xE7%3B%26%23xF5%3Bes%20farmacocin%26%23xE9%3Bticas%20e%20farmacodin%26%23xE2%3Bmicas%20com%20as%20associa%26%23xE7%3B%26%23xF5%3Bes%20ebastina%20e%20cetoconazol%20ou%20eritromicina%20(ambos%20conhecidos%20por%20prolongar%20o%20intervalo%20QT)%2C%20relatando-se%20um%20aumento%20de%2018-19%20mseg%20(4%2C7%20%26%23x2013%3B%205%25)%20no%20intervalo%20QT.%3Cbr%3E%20%3Cbr%3E%20Interfer%26%23xEA%3Bncia%20em%20exames%20laboratoriais%3Cbr%3E%20A%20ebastina%20pode%20interferir%20no%20resultado%20de%20teste%20al%26%23xE9%3Brgico%20cut%26%23xE2%3Bneo%2C%20sendo%20prudente%20n%26%23xE3%3Bo%20realiz%26%23xE1%3B-lo%20no%20per%26%23xED%3Bodo%20de%205%20a%207%20dias%20ap%26%23xF3%3Bs%20a%20suspens%26%23xE3%3Bo%20do%20tratamento.%3Cbr%3E%20%3Cbr%3E%20Efeitos%20sobre%20a%20habilidade%20para%20dirigir%20e%20operar%20m%26%23xE1%3Bquinas%3Cbr%3E%20O%20uso%20de%20Ebastel%26%23xAE%3B%20(ebastina)%20nas%20doses%20terap%26%23xEA%3Buticas%20recomendadas%20n%26%23xE3%3Bo%20afeta%20a%20habilidade%20para%20dirigir%20ou%20operar%20m%26%23xE1%3Bquinas.%3Cbr%3E%20Este%20medicamento%20cont%26%23xE9%3Bm%20LACTOSE.%3Cbr%3E%20Informe%20ao%20seu%20m%26%23xE9%3Bdico%20ou%20cirurgi%26%23xE3%3Bo-dentista%20se%20voc%26%23xEA%3B%20est%26%23xE1%3B%20fazendo%20uso%20de%20algum%20outro%20medicamento.%20N%26%23xE3%3Bo%20use%20medicamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%20Pode%20ser%20perigoso%20para%20a%20sua%20sa%26%23xFA%3Bde.%3Cbr%3E%20%3Cbr%3E%205.ONDE%2C%20COMO%20E%20POR%20QUANTO%20TEMPO%20POSSO%20GUARDAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20deve%20ser%20mantido%20em%20sua%20embalagem%20original%2C%20conservado%20em%20temperatura%20ambiente%20(entre%2015%26%23xB0%3BC%20e%2030%26%23xB0%3BC).%20Proteger%20da%20luz%20e%20umidade.%3Cbr%3E%20%3Cbr%3E%20N%26%23xFA%3Bmero%20de%20lote%20e%20datas%20de%20fabrica%26%23xE7%3B%26%23xE3%3Bo%20e%20validade%3A%20vide%20embalagem.%3Cbr%3E%20N%26%23xE3%3Bo%20use%20medicamento%20com%20o%20prazo%20de%20validade%20vencido.%20Guarde-o%20em%20sua%20embalagem%20original.%3Cbr%3E%20%3Cbr%3E%20Caracter%26%23xED%3Bsticas%20do%20comprimido%3A%20Ebastel%26%23xAE%3B%20(ebastina)%20%26%23xE9%3B%20um%20%26%23xE9%3B%20um%20c%20Branco%3Cbr%3E%20%3Cbr%3E%20Antes%20de%20usar%2C%20observe%20o%20aspecto%20do%20medicamento.%20Caso%20ele%20esteja%20no%20prazo%20de%20validade%20e%20voc%26%23xEA%3B%20observe%20alguma%20mudan%26%23xE7%3Ba%20no%20aspecto%2C%20consulte%20o%20farmac%26%23xEA%3Butico%20para%20saber%20se%20poder%26%23xE1%3B%20utiliz%26%23xE1%3B-lo.%3Cbr%3E%20Todo%20medicamento%20deve%20ser%20mantido%20fora%20do%20alcance%20das%20crian%26%23xE7%3Bas.%3Cbr%3E%20%3Cbr%3E%206.COMO%20DEVO%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Ebastel%26%23xAE%3B%20(ebastina)%20comprimidos%20deve%20ser%20administrado%20a%20adultos%20e%20crian%26%23xE7%3Bas%20maiores%20de%2012%20anos%20nas%20seguintes%20doses%3A%3Cbr%3E%20%3Cbr%3E%20Rinite%20al%26%23xE9%3Brgica%3A%20um%20comprimido%20de%2010%20mg%2C%20administrado%20uma%20vez%20ao%20dia.%20Em%20pacientes%20com%20sintomas%20mais%20intensos%2C%20incluindo%20rinite%20al%26%23xE9%3Brgica%20sazonal%2C%20a%20dose%20de%2020%20mg%20(dois%20comprimidos%20de%2010%20mg)%20administrada%20uma%20vez%20ao%20dia%20promove%20maior%20al%26%23xED%3Bvio%20dos%20sintomas.%3Cbr%3E%20%3Cbr%3E%20Urtic%26%23xE1%3Bria%3A%20um%20comprimido%20de%2010%20mg%20administrado%20uma%20vez%20ao%20dia.%3Cbr%3E%20A%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento%20deve%20ser%20determinada%20pelo%20m%26%23xE9%3Bdico%20que%20prescreveu%20Ebastel%26%23xAE%3B%20(ebastina).%3Cbr%3E%20%3Cbr%3E%20Popula%26%23xE7%3B%26%23xF5%3Bes%20especiais%3A%3Cbr%3E%20Em%20pacientes%20com%20insufici%26%23xEA%3Bncia%20hep%26%23xE1%3Btica%20leve%20a%20moderada%2C%20n%26%23xE3%3Bo%20se%20deve%20exceder%20a%20dose%20de%2010%20mg.%3Cbr%3E%20%3Cbr%3E%20Siga%20a%20orienta%26%23xE7%3B%26%23xE3%3Bo%20de%20seu%20m%26%23xE9%3Bdico%2C%20respeitando%20sempre%20os%20hor%26%23xE1%3Brios%2C%20as%20doses%20e%20a%20dura%26%23xE7%3B%26%23xE3%3Bo%20do%20tratamento.%20N%26%23xE3%3Bo%20interrompa%20o%20tratamento%20sem%20o%20conhecimento%20do%20seu%20m%26%23xE9%3Bdico.%3Cbr%3E%20Este%20medicamento%20n%26%23xE3%3Bo%20deve%20ser%20partido%2C%20aberto%20ou%20mastigado.%3Cbr%3E%20%3Cbr%3E%207.%20O%20QUE%20DEVO%20FAZER%20QUANDO%20EU%20ME%20ESQUECER%20DE%20USAR%20ESTE%20MEDICAMENTO%3F%3Cbr%3E%20Use%20a%20medica%26%23xE7%3B%26%23xE3%3Bo%20assim%20que%20se%20lembrar%20de%20que%20esqueceu%20uma%20dose.%20Se%20o%20hor%26%23xE1%3Brio%20estiver%20pr%26%23xF3%3Bximo%20ao%20que%20seria%20a%20dose%20seguinte%2C%20pule%20a%20dose%20perdida%20e%20siga%20o%20hor%26%23xE1%3Brio%20das%20outras%20doses%20normalmente.%20N%26%23xE3%3Bo%20dobre%20a%20dose%20para%20compensar%20a%20dose%20omitida.%3Cbr%3E%20%3Cbr%3E%20Em%20caso%20de%20d%26%23xFA%3Bvidas%2C%20procure%20orienta%26%23xE7%3B%26%23xE3%3Bo%20do%20farmac%26%23xEA%3Butico%20ou%20de%20seu%20m%26%23xE9%3Bdico%2C%20ou%20cirurgi%26%23xE3%3Bo-dentista.%3Cbr%3E%20%3Cbr%3E%208.QUAIS%20OS%20MALES%20QUE%20ESTE%20MEDICAMENTO%20PODE%20ME%20CAUSAR%3F%3Cbr%3E%20Os%20eventos%20adversos%20de%20Ebastel%26%23xAE%3B%20(ebastina)%20s%26%23xE3%3Bo%20apresentados%20em%20ordem%20de%20frequ%26%23xEA%3Bncia%20decrescente%20a%20seguir%3A%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20comum%20(ocorre%20entre%201%25%20e%2010%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20dor%20de%20cabe%26%23xE7%3Ba%2C%20tontura%20e%20boca%20seca.%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20incomum%20(ocorre%20entre%200%2C1%25%20e%201%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20dor%20no%20abd%26%23xF4%3Bmen%2C%20sensa%26%23xE7%3B%26%23xE3%3Bo%20de%20peso%20no%20est%26%23xF4%3Bmago%2C%20sangramento%20nasal%2C%20rinite%2C%20sinusite%2C%20n%26%23xE1%3Busea%2C%20ins%26%23xF4%3Bnia%2C%20faringite%2C%20fraqueza.%3Cbr%3E%20Rea%26%23xE7%3B%26%23xE3%3Bo%20muito%20rara%20(ocorre%20em%20menos%20de%200%2C01%25%20dos%20pacientes%20que%20utilizam%20este%20medicamento)%3A%20palpita%26%23xE7%3B%26%23xE3%3Bo%2C%20sonol%26%23xEA%3Bncia%2C%20nervosismo%2C%20urtic%26%23xE1%3Bria.%3Cbr%3E%20Informe%20a%20seu%20m%26%23xE9%3Bdico%2C%20cirurgi%26%23xE3%3Bo-dentista%20ou%20farmac%26%23xEA%3Butico%20o%20aparecimento%20de%20rea%26%23xE7%3B%26%23xF5%3Bes%20indesej%26%23xE1%3Bveis%20pelo%20uso%20do%20medicamento.%20Informe%20tamb%26%23xE9%3Bm%20a%20empresa%20atrav%26%23xE9%3Bs%20de%20seu%20servi%26%23xE7%3Bo%20de%20atendimento.%3Cbr%3E%20%3Cbr%3E%209.%20O%20QUE%20FAZER%20SE%20ALGU%26%23xC9%3BM%20USAR%20UMA%20QUANTIDADE%20MAIOR%20DO%20QUE%20A%20INDICADA%20DESTE%20MEDICAMENTO%3F%3Cbr%3E%20Caso%20ocorra%20ingest%26%23xE3%3Bo%20de%20uma%20quantidade%20maior%20que%20a%20indicada%20deste%20medicamento%2C%20procure%20imediatamente%20orienta%26%23xE7%3B%26%23xE3%3Bo%20m%26%23xE9%3Bdica.%20N%26%23xE3%3Bo%20existe%20ant%26%23xED%3Bdoto%20espec%26%23xED%3Bfico%20para%20a%20ebastina.%20Em%20caso%20de%20superdosagem%2C%20deve-se%20realizar%20lavagem%20g%26%23xE1%3Bstrica%20(lavagem%20do%20est%26%23xF4%3Bmago)%2C%20monitoriza%26%23xE7%3B%26%23xE3%3Bo%20das%20fun%26%23xE7%3B%26%23xF5%3Bes%20vitais%20incluindo%20eletrocardiograma%2C%20e%20tratamento%20dos%20sintomas%20observados.%3Cbr%3E%20%3Cbr%3E%20Em%20caso%20de%20uso%20de%20grande%20quantidade%20deste%20medicamento%2C%20procure%20rapidamente%20socorro%20m%26%23xE9%3Bdico%20e%20leve%20a%20embalagem%2C%20ou%20bula%20do%20medicamento%2C%20se%20poss%26%23xED%3Bvel.%20Ligue%20para%200800%20722%206001%2C%20se%20voc%26%23xEA%3B%20precisar%20de%20mais%20orienta%26%23xE7%3B%26%23xF5%3Bes.%3Cbr%3E%3C%2Fp%3E%0A%3Ch2%3EData%20da%20bula%3C%2Fh2%3E%0A%3Cp%3E16%2F07%2F2014%3C%2Fp%3E%0A%09%09%09%09%09%09
Ame
Não
ApresentarPrecoDePor
Sim
custom_label_0
campanha
Cashback
Não

Tributos e contexto fiscal

Escolha o estado para ver os tributos deste produto:
Preferência salva neste navegador; confirme o destino da operação.

NCM, CEST e tributos são referências fiscais brasileiras e podem não se aplicar em outros países.

Selecione a UF nesta seção para consultar a estimativa IBPT.

IBS/CBS: o cClassTrib acima vem do enquadramento do NCM; percentuais dependem da operação, regime, data e destino.

Medicamento — dados oficiais

Medicamento
EBASTEL 1 MG/ML XPE CT FR VD AMB X 60 ML
Princípio ativo
EBASTINA
Laboratório
EUROFARMA LABORATORIOS S.A.
Registro ANVISA
1004307600031
Classe terapêutica
R6A - ANTI-HISTAMÍNICOS SISTÊMICOS
Tipo
Novo
Tarja
Tarja Sem Tarja
PIS/COFINS
Lista negativa (PIS/COFINS monofásico, sem crédito presumido)

Fonte: CMED/ANVISA, lista de preços de medicamentos publicada em 09/10/2026. Confirme a tributação com seu contador.

EBASTEL XPE - EUROFARMA

Dados estruturados

Veja todos os dados deste produto em JSON.

É exatamente o que a API devolve para este código de barras — pronto para o seu ERP, PIM ou PDV.

GET https://global.si5.com.br/api/produtos/7891317000547


            

Para chamar a API de verdade você usa um token pessoal — grátis até 100 consultas por dia.

Histórico de preços

Como o preço deste produto variou.

Preços de referência coletados em lojas online. Uma nova coleta acontece a cada cerca de 30 dias e sempre que o preço muda.

Último preçoR$ 61,99
Variação no período—
Menor / maiorR$ 61,99 / R$ 61,99
Coletas1
DataPreçoVariaçãoFonte
03/10/2026 R$ 61,99 primeira coleta paguemenos.com.br

Valores informativos coletados de lojas online, sem garantia de que estejam atualizados. Não representam preço de venda do SI5 Global.